United States Biotechnology & Medical Research

Adolor Corp (ADLR)

Track

Ticker: ADLR Exchange: NMQ
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Buy 12 Dec 2011
Value US$4,970,542.60 | Price 214.93 | Shares 69,647 (+18.1%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2011-12-13 2011-12-12 B Purchase CUBIST PHARMACEUTICALS INC Large shareholder
69,647 +18.1%
214.93
US$4,970,543 		69,647 +18.1% 214.93 US$4,970,543
2011-12-13 2011-12-09 B Purchase CUBIST PHARMACEUTICALS INC Large shareholder
64,704 -8.3%
280.46
US$2,284,185 		64,704 -8.3% 280.46 US$2,284,185
2011-12-13 2011-12-09 B Purchase CUBIST PHARMACEUTICALS INC Large shareholder
9,609 -29.8%
40.67
US$3,239,081 		9,609 -29.8% 40.67 US$3,239,081
2011-12-09 2011-12-08 B Purchase CUBIST PHARMACEUTICALS INC Large shareholder
1,180,983 +2.9%
4.25
US$5,019,178 		1,180,983 +2.9% 4.25 US$5,019,178
2011-12-09 2011-12-07 B Purchase CUBIST PHARMACEUTICALS INC Large shareholder
4,306,129 +11.9%
4.25
US$18,301,048 		4,306,129 +11.9% 4.25 US$18,301,048
2011-12-08 2011-12-06 B Purchase MADDEN DAVID Non-Executive Director
18,425 +1.7%
4.66
US$85,860 		18,425 +1.7% 4.66 US$85,860
2011-12-08 2011-12-06 B Purchase MADDEN DAVID Non-Executive Director
61,650 +6.0%
4.65
US$286,672 		61,650 +6.0% 4.65 US$286,672
2011-12-02 2011-12-02 B Purchase NICKELSON DONALD E Non-Executive Director
35,000 +11.4%
4.62
US$161,700 		35,000 +11.4% 4.62 US$161,700
2011-12-02 2011-12-02 B Purchase NICKELSON DONALD E Non-Executive Director
100,000 +48.1%
4.67
US$467,000 		100,000 +48.1% 4.67 US$467,000
2011-12-02 2011-12-02 B Purchase NICKELSON DONALD E Non-Executive Director
72,896 +53.9%
4.73
US$344,798 		72,896 +53.9% 4.73 US$344,798
2011-11-30 2011-11-22 B Purchase NICKELSON DONALD E Non-Executive Director
2,643 +2.0%
4.58
US$12,105 		2,643 +2.0% 4.58 US$12,105
2011-11-30 2011-11-21 B Purchase NICKELSON DONALD E Non-Executive Director
24,461 +22.6%
4.59
US$112,276 		24,461 +22.6% 4.59 US$112,276
2011-06-27 2011-06-27 B Purchase Webster Stephen W

SVP, Finance & CFO

Officer
10,000 +7.8%
1.88
US$18,800 		10,000 +7.8% 1.88 US$18,800
2011-06-22 2011-06-15 B Purchase Limongelli John M

SVP, General Counsel & Secr.

Officer
3,010 +1.6%
1.80
US$5,418 		3,010 +1.6% 1.80 US$5,418
2011-06-22 2011-06-14 B Purchase Limongelli John M

SVP, General Counsel & Secr.

Officer
13,190 +7.6%
1.90
US$25,061 		13,190 +7.6% 1.90 US$25,061
2010-12-23 2010-12-23 B Purchase DOUGHERTY MICHAEL R

President & CEO

Executive Director
30,000 +5.1%
1.18
US$35,400 		30,000 +5.1% 1.18 US$35,400
2010-10-29 2010-10-29 S Sale Baker Biotech Capital (GP), LLC Large shareholder
376 -0.5%
1.18
US$445 		376 -0.5% 1.18 US$445
2010-10-29 2010-10-29 S Sale Baker Bros. Capital (GP), LLC Large shareholder
14 -0.5%
1.18
US$17 		14 -0.5% 1.18 US$17
2010-10-29 2010-10-29 S Sale 14159 capital (GP), LLC Large shareholder
884 -0.5%
1.18
US$1,046 		884 -0.5% 1.18 US$1,046
2010-10-29 2010-10-29 S Sale Baker / Tisch Capital (GP), LLC Large shareholder
60 -0.5%
1.18
US$71 		60 -0.5% 1.18 US$71
2010-10-29 2010-10-29 S Sale Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
31,666 -0.5%
1.18
US$37,461 		31,666 -0.5% 1.18 US$37,461
2010-10-29 2010-10-28 S Sale Baker Biotech Capital (GP), LLC Large shareholder
885 -1.1%
1.19
US$1,052 		885 -1.1% 1.19 US$1,052
2010-10-29 2010-10-28 S Sale Baker Bros. Capital (GP), LLC Large shareholder
33 -1.1%
1.19
US$39 		33 -1.1% 1.19 US$39
2010-10-29 2010-10-28 S Sale 14159 capital (GP), LLC Large shareholder
2,086 -1.1%
1.19
US$2,479 		2,086 -1.1% 1.19 US$2,479
2010-10-29 2010-10-28 S Sale Baker / Tisch Capital (GP), LLC Large shareholder
142 -1.1%
1.19
US$169 		142 -1.1% 1.19 US$169
2010-10-29 2010-10-28 S Sale Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
74,670 -1.1%
1.19
US$88,738 		74,670 -1.1% 1.19 US$88,738
2010-10-29 2010-10-27 S Sale Baker Biotech Capital (GP), LLC Large shareholder
569 -0.7%
1.30
US$740 		569 -0.7% 1.30 US$740
2010-10-29 2010-10-27 S Sale Baker Bros. Capital (GP), LLC Large shareholder
21 -0.7%
1.30
US$27 		21 -0.7% 1.30 US$27
2010-10-29 2010-10-27 S Sale 14159 capital (GP), LLC Large shareholder
1,341 -0.7%
1.30
US$1,743 		1,341 -0.7% 1.30 US$1,743
2010-10-29 2010-10-27 S Sale Baker / Tisch Capital (GP), LLC Large shareholder
91 -0.7%
1.30
US$118 		91 -0.7% 1.30 US$118
2010-10-29 2010-10-27 S Sale Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
47,978 -0.7%
1.30
US$62,371 		47,978 -0.7% 1.30 US$62,371
2010-10-29 2010-10-27 S Sale Baker Biotech Capital (GP), LLC Large shareholder
233 -0.3%
1.28
US$298 		233 -0.3% 1.28 US$298
2010-10-29 2010-10-27 S Sale Baker Bros. Capital (GP), LLC Large shareholder
9 -0.3%
1.28
US$11 		9 -0.3% 1.28 US$11
2010-10-29 2010-10-27 S Sale 14159 capital (GP), LLC Large shareholder
550 -0.3%
1.28
US$702 		550 -0.3% 1.28 US$702
2010-10-29 2010-10-27 S Sale Baker / Tisch Capital (GP), LLC Large shareholder
37 -0.3%
1.28
US$47 		37 -0.3% 1.28 US$47
2010-10-29 2010-10-27 S Sale Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
19,671 -0.3%
1.28
US$25,120 		19,671 -0.3% 1.28 US$25,120
2010-06-02 2010-06-01 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
2,238 +0.0%
1.58
US$3,536 		2,238 +0.0% 1.58 US$3,536
2010-06-02 2010-06-01 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
405,401 +6.3%
1.64
US$664,736 		405,401 +6.3% 1.64 US$664,736
2010-06-02 2010-06-01 B Purchase 14159 capital (GP), LLC Large shareholder
62 +0.0%
1.58
US$98 		62 +0.0% 1.58 US$98
2010-06-02 2010-06-01 B Purchase 14159 capital (GP), LLC Large shareholder
11,190 +6.2%
1.64
US$18,348 		11,190 +6.2% 1.64 US$18,348
2010-06-02 2010-05-28 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
21,604 +0.3%
1.56
US$33,750 		21,604 +0.3% 1.56 US$33,750
2010-06-02 2010-05-28 B Purchase 14159 capital (GP), LLC Large shareholder
596 +0.3%
1.56
US$931 		596 +0.3% 1.56 US$931
2010-06-02 2010-05-28 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
517,045 +8.8%
1.60
US$828,409 		517,045 +8.8% 1.60 US$828,409
2010-06-02 2010-05-28 B Purchase 14159 capital (GP), LLC Large shareholder
14,272 +8.6%
1.60
US$22,867 		14,272 +8.6% 1.60 US$22,867
2010-05-27 2010-05-27 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
44,862 +0.8%
1.60
US$71,640 		44,862 +0.8% 1.60 US$71,640
2010-05-27 2010-05-27 B Purchase 14159 capital (GP), LLC Large shareholder
1,238 +0.8%
1.60
US$1,977 		1,238 +0.8% 1.60 US$1,977
2010-05-27 2010-05-26 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
64,420 +1.1%
1.59
US$102,196 		64,420 +1.1% 1.59 US$102,196
2010-05-27 2010-05-26 B Purchase 14159 capital (GP), LLC Large shareholder
1,778 +1.1%
1.59
US$2,821 		1,778 +1.1% 1.59 US$2,821
2010-05-27 2010-05-25 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
68,534 +1.2%
1.60
US$109,558 		68,534 +1.2% 1.60 US$109,558
2010-05-27 2010-05-25 B Purchase 14159 capital (GP), LLC Large shareholder
1,892 +1.2%
1.60
US$3,025 		1,892 +1.2% 1.60 US$3,025
2010-05-03 2010-04-30 B Purchase 14159 capital (GP), LLC Large shareholder
970 +0.6%
1.99
US$1,928 		970 +0.6% 1.99 US$1,928
2010-05-03 2010-04-30 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
35,130 +0.6%
1.99
US$69,824 		35,130 +0.6% 1.99 US$69,824
2010-05-03 2010-04-29 B Purchase 14159 capital (GP), LLC Large shareholder
124 +0.1%
1.94
US$240 		124 +0.1% 1.94 US$240
2010-05-03 2010-04-29 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
4,508 +0.1%
1.94
US$8,740 		4,508 +0.1% 1.94 US$8,740
2010-04-28 2010-04-28 B Purchase 14159 capital (GP), LLC Large shareholder
3,094 +2.0%
1.92
US$5,938 		3,094 +2.0% 1.92 US$5,938
2010-04-28 2010-04-28 B Purchase 14159 capital (GP), LLC Large shareholder
962 +0.6%
1.82
US$1,753 		962 +0.6% 1.82 US$1,753
2010-04-28 2010-04-28 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
112,106 +2.0%
1.92
US$215,165 		112,106 +2.0% 1.92 US$215,165
2010-04-28 2010-04-28 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
34,838 +0.6%
1.82
US$63,482 		34,838 +0.6% 1.82 US$63,482
2010-04-28 2010-04-27 B Purchase 14159 capital (GP), LLC Large shareholder
98 +0.1%
2.06
US$202 		98 +0.1% 2.06 US$202
2010-04-28 2010-04-27 B Purchase 14159 capital (GP), LLC Large shareholder
217 +0.1%
2.08
US$451 		217 +0.1% 2.08 US$451
2010-04-28 2010-04-27 B Purchase 14159 capital (GP), LLC Large shareholder
609 +0.4%
2.08
US$1,267 		609 +0.4% 2.08 US$1,267
2010-04-28 2010-04-27 B Purchase 14159 capital (GP), LLC Large shareholder
489 +0.3%
2.08
US$1,016 		489 +0.3% 2.08 US$1,016
2010-04-28 2010-04-27 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
3,550 +0.1%
2.06
US$7,313 		3,550 +0.1% 2.06 US$7,313
2010-04-28 2010-04-27 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
7,858 +0.1%
2.08
US$16,342 		7,858 +0.1% 2.08 US$16,342
2010-04-28 2010-04-27 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
22,055 +0.4%
2.08
US$45,894 		22,055 +0.4% 2.08 US$45,894
2010-04-28 2010-04-27 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
17,709 +0.3%
2.08
US$36,790 		17,709 +0.3% 2.08 US$36,790
2010-04-28 2010-04-26 B Purchase 14159 capital (GP), LLC Large shareholder
1,222 +0.8%
2.05
US$2,509 		1,222 +0.8% 2.05 US$2,509
2010-04-28 2010-04-26 B Purchase 14159 capital (GP), LLC Large shareholder
11 +0.0%
2.06
US$23 		11 +0.0% 2.06 US$23
2010-04-28 2010-04-26 B Purchase 14159 capital (GP), LLC Large shareholder
1,393 +0.9%
2.07
US$2,885 		1,393 +0.9% 2.07 US$2,885
2010-04-28 2010-04-26 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
44,258 +0.8%
2.05
US$90,862 		44,258 +0.8% 2.05 US$90,862
2010-04-28 2010-04-26 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
389 +0.0%
2.06
US$801 		389 +0.0% 2.06 US$801
2010-04-28 2010-04-26 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
50,451 +0.9%
2.07
US$104,489 		50,451 +0.9% 2.07 US$104,489
2010-04-28 2010-04-26 B Purchase 14159 capital (GP), LLC Large shareholder
159 +0.1%
2.06
US$328 		159 +0.1% 2.06 US$328
2010-04-28 2010-04-26 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
5,755 +0.1%
2.06
US$11,855 		5,755 +0.1% 2.06 US$11,855
2009-09-24 2009-09-22 S Sale BVF PARTNERS L P/IL

Direct Beneficial Owner

Large shareholder
166,000 -3.9%
1.69
US$280,972 		166,000 -3.9% 1.69 US$280,972
Explore more

More insider trading research around Adolor Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America